The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

TESARO Inc

Nasdaq: TSRO
Last

(U.S.) $36.09

Today's change+1.13 +3.23%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.
 

TESARO Inc

Nasdaq: TSRO
Last

(U.S.) $36.09

Today's change+1.13 +3.23%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

TESARO Inc crosses above 20-day moving average

TESARO Inc closed up sharply Friday, rallying (U.S.)$1.13 or 3.23% to (U.S.)$36.09 and crossing above its 20-day moving average. Over the last five days, shares have gained 1.69%, but are down 31.02% for the last year to date. Shares have outperformed the S&P 500 by 2.50% during the last year.

Key company metrics

  • Open(U.S.) $35.75
  • Previous close(U.S.) $34.96
  • High(U.S.) $36.50
  • Low(U.S.) $33.90
  • Bid / Ask-- / --
  • YTD % change-31.02%
  • Volume619,764
  • Average volume (10-day)721,061
  • Average volume (1-month)628,148
  • Average volume (3-month)554,000
  • 52-week range(U.S.) $29.51 to (U.S.) $66.95
  • Beta1.75
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$5.81
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-256,993.10%

TESARO Inc has a net profit margin of -256,993.10%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Biotechnology

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense63574544
Selling / general / administrative2317117
Research & development40393430
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0107
Other operating expenses, total--------
Operating income-63-57-45-44
Interest income (expense), net non-operating-4-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-67-61-49-48
Income after tax-67-61-49-48
Income tax, total------0
Net income-67-61-49-48
Total adjustments to net income--------
Net income before extra. items-67-61-49-48
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-67-61-49-48
Inc. avail. to common incl. extra. items-67-61-49-48
Diluted net income-67-61-49-48
Dilution adjustment--------
Diluted weighted average shares40403736
Diluted EPS excluding extraordinary itemsvalue per share-1.66-1.51-1.30-1.33
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-1.66-1.49-1.30-1.13